US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug

Retrieved on: 2025-01-27 19:18:40

Tags for this article:

Click the tags to see associated articles and topics

US Patent Office Granted Can-Fite Namodenoson Patent for Use as anti-Obesity Drug. View article details on hiswai:

Excerpt

Ramat Gan, Israel, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CANF), a biotechnology company advancing ...

Article found on: markets.businessinsider.com